Background Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materials. Objectives To provide policy makers, physicians, and researchers information on the relative importance of physician recommendations and early state-level policies to promote HPV vaccinations among targeted age groups. Methods We first use probit models to determine the strongest correlates of immunization in a nationally representative US sample of teenagers. We then use instrumental variable probit models to determine the direct role that physician recommendations play in vaccination using plausibly exogenous physician encounters that are likely not the result of more health-conscious parents seeking out information on the vaccine. Results We show that children in the targeted age range who are more likely to encounter physicians for reasons other than seeking out the vaccine, such as through mandatory wellness exams or previous asthma diagnoses, are significantly more likely to get the vaccine. There is no consistent evidence that the state policies we analyze have been effective. Conclusion Encouraging recommendations by physicians may be the most effective path toward increasing HPV vaccination. State-level mandates and policies are yet to exhibit effectiveness.
Introduction
The human papillomavirus (HPV) is the most common sexually transmitted infection in the USA [1] . Vaccines such as Cervarix and Gardasil can protect against the most common symptomatic types of HPV. Cervarix was approved in 2009 by the US Food and Drug Administration (FDA), and Gardasil was approved in 2006 [2] . The Advisory Committee on Immunization Practices (ACIP) recommends either HPV vaccine for routine vaccination for all girls 11-12 years old and catch-up vaccination for those 13-26 years old who have not been vaccinated previously. 1 Moreover, there have been efforts to synchronize HPV vaccine delivery with other required vaccines [3] . Despite this, only about one-third of 13-to 17-year-old girls have received the complete three-dose sequence of the vaccine. According to calculations we present later, only half of children in this age range are provided a recommendation from their physician to get vaccinated. The low vaccination rate is a public health issue that many states have attempted to address. There are several explanations for the failure of widespread vaccination despite clear benefits. Depending on health insurance status, parents might have to pay part or all of the cost of the vaccine [4] . A full course of HPV vaccination costs about US$390, 2 which is significantly more expensive than most other required vaccines. Another potential barrier is lack of awareness that the vaccine exists and its benefits [5] . Finally, many parents believe their daughter is not sexually active or the child is not of the appropriate age [6, 7] .
In this paper, we focus on both the role of physician recommendations and two policies enacted by several states-outright mandates and provision of educational materials for parents. The most contentious existing policy is school mandates because it restricts parental choice in a matter related to teen sexuality [8] . The most prevalent alternative state policy is the provision of educational content about HPV to parents. There are also states that require health education for students to cover the information about HPV, but these requirements tend not to be binding as school districts often decide whether to include it in their curriculum. During the same period, some states have mandated health insurance policies to include the HPV vaccine in their preventive services. Because of the heterogeneity in provisions across states and the fact that many were in place long before the introduction of HPV vaccines, it is beyond the scope of this paper to estimate the causal effect of these health insurance provisions.
To the best of our knowledge, Bugenske et al. [9] provided the only published study that explicitly investigates the effect of school policies, including mandates and parental education, finding no strong associations of these policies and HPV vaccination. They used mean comparisons between treatment and control states. Our study will explicitly control for the differences in state characteristics and employ individual-level data.
Healthcare providers are typically one of the most influential sources on patients' health-related decisions [10] [11] [12] . The attitudes of physicians and their willingness to promote vaccination among their patients has been the subject of discussion in the influenza literature [13, 14] , with access to providers through a medical home being important to the acceptance of vaccines [15] . Some studies suggest a strong role for physicians in HPV vaccine initiation [7, [16] [17] [18] [19] . However, the advantage of our study over these studies is that we model physician encounters as coming from sources that have little to do with the more health-conscious parents being motivated to get an HPV vaccination recommendation and subsequent vaccination. This correlation with omitted factors like health-conscious parents or general access to the healthcare system might bias the observed correlation between recommendations and vaccination. In addition to controlling for these other factors, we identify several cases where such recommendations come from physician encounters that are for reasons that are likely unrelated to HPV vaccination. In these cases, we use two stage instrumental variable probit models to provide estimates that identify more closely the casual effects of doctor recommendations on vaccination.
Methods

Data
Our data come from the 2008-2011 National Immunization Survey-Teen (NIS-Teen), which covers all 50 states and DC and includes records of children aged 13-17 years. The NIS is a representative sample of parents, along with follow-up mail surveys to the respondents' immunization providers.
3 This is the period in which most states enacted the HPV-related regulations we study. This database also collects information on receiving a recommendation from a physician concerning HPV vaccination.
We merge the NIS-Teen data to information on the enactment of HPV-related regulations in different states that are summarized in Table 1 . The content of educational packages distributed to parents is similar in different states, but each state has targeted a different age group. Although DC and Virginia are defined as the two ''school mandate'' jurisdictions, they are somewhat different in terms of optout clauses and enforcement. 4 We define our treatment group as anybody who has been subject to these state policies at any time in their past based 1 ACIP provided guidance that Gardasil may be given to males aged 9 through 26 years in October 2006 but did not recommend the HPV vaccine for routine use among males. ACIP recommended routine use of Gardasil in males aged 11 and 12 years on 25 October 2011. 2 See https://www.arhp.org/Publications-and-Resources/Patient-Reso urces/Fact-Sheets/Understanding-HPV-Vaccine. . This is the year that our sample begins. However, Illinois, Indiana, and Washington enacted their policies only for sixth grade students, and as a result every year a bigger group of girls are covered by the policy. For example, a 13-year-old girl in Indiana at 2010 was not in the covered age group, but she was in the covered age group sometime after the law's enactment. This is also true of 13-and 14-year-old girls at 2011. This provides us with ample variation to identify the effect of educational programs for parents.
Sample Selection
We restrict the sample to females because mostly just girls are subject to these provisions. Educational programs for students are not binding most of the time, so it is impossible to determine whether an individual had ever received any educational content about HPV. A full course of HPV vaccination costs about US$390, which is significantly more expensive than most other required vaccines, and health insurance coverage likely influences the vaccination rates. To address this, some states enacted legislations to require health insurance plans to include HPV vaccine in their preventive services. However, health insurance requirements and cost-sharing policies are heterogeneous across states. Coverage of the vaccine may be subject to deductibles and co-insurance depending on the health insurance plan. Moreover, many health insurance policies had included HPV vaccine in their preventive services regardless of legal requirements by states. As a result, it is impossible to adequately control for this variable because we are unable to construct a reliable control group for this policy. Thus, we considered both dropping these states from our analysis and including the states, with controls added to control for the fact that policies existed within these states. We opted for the latter, but the results are similar regardless of the approach. Other states offer a wide range of programs to cover the cost of the childhood immunizations that might interact with HPV vaccination [20] . This includes provision of federal and state funds to cover the cost of the vaccination, 5 and requiring insurance companies to cover childhood immunizations. 6 States vary on which immunizations to cover and the cost-sharing policies [21] . Because of the heterogeneity in provisions across states and the fact that many were in place long before the introduction of HPV vaccines, it is beyond the scope of this paper to estimate the causal effect of these health insurance provisions. There are also states that have public awareness campaigns (Colorado, North Dakota, and Utah). Fortunately, all of these states had these policies in effect the whole sample period, and state dummies should control for the effect of these policies. So, these states remain in our analysis. 7 Our final sample consists of 65,415 observations across 50 states and DC. Table 1 lists each state, with information on their policies regarding HPV vaccination. Table 1 also reports the state specific means of outcomes.
Basic Model
We estimate
using a probit model. 8 Y ijt is a variable that represents the vaccine initiation (dose C1), or the completion of the threedose vaccine sequence (dose C3). In some specifications, we use a variable that indicates whether a child has initiated the vaccine before the age of 13 years. We initially use the data reported by providers to construct the dependent variable; however, when these data are missing, we use the household reports. 9 The variable school mandate is a dummy variable indicating that a child lives in a state where school mandates for HPV vaccines are in effect and the child has been in the covered age group of the legislation at any time after the law was enacted. The variable education for parents is a dummy variable that indicates the respondent lives in a state in which educational content about HPV is being distributed among parents, and they were in the targeted age group at any time after the law's enactment. The variable recommendation is a dummy variable indicating that parents had received a recommendation regarding the HPV vaccine from a physician. The vector c j is a set of state dummy variables that are intended to capture time-invariant factors that cause Y to differ between states. The vector d t is a set of year dummies that captures the difference in Y in different years that are common among the states. We also include the interaction of age dummies and year dummies to allow Y to vary differently over time by age groups.
X ijt is a vector of control covariates. A supplementary electronic file includes definitions of all controls used in the analysis. We include controls for age, mother's marital status, mother's education, mother's age categories, race, number of children below the age of 18 years in the household, number of people in the household, income, teen health status, and overall health status within the household. With the exception of the maternal controls, all controls refer to the child. The X vector also contains information about health insurance status. Health insurance status/type is divided into private, public, and military. Many physicians do not treat publicly insured patients [22] . Physicians are less willing to accept any new Medicaid patients compared with private health insurance holders after Affordable Care Act enactment [23] . We include two 5 Federal programs include Vaccine for Children (VFC) program, and Section 317 of the Public Health Services Act. At the state level, Universal Purchase programs (dubbed as ''universal states'') supplement federal funds to provide ACIP-recommended vaccines for privately insured children, as well as Vaccine for Children (VFC) eligible ones (Alaska, New Hampshire, New Mexico, Rhode Island, Vermont, Washington, and Wyoming). Alaska changed its status in January 2009, Washington in July 2009, and Wyoming in July 2011 to ''universal select'' states, meaning that they cover all but selected vaccines (not including the HPV vaccine). 6 This includes Arkansas, California, Colorado, Connecticut, Delaware, DC, Florida, Georgia, Hawaii, Illinois, Kansas, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, Texas, Virginia, West Virginia, and Wisconsin. In addition to those states, a new insurances and plans under the ACA are required to provide preventive services as of 23 September 2010, including ACIP-recommended vaccines without imposing out of pocket costs on the policy holder such as co-payment or co-insurances. 7 We initially include all the universal states and the states with a public awareness campaigns. We drop those states that have changed their status to ''universal select'' during the sample period (Alaska and Washington) for robustness check. These results are qualitatively the same and will be available upon request. 8 Results are robust to linear probability models, which do not have the complications arising from incidental parameters, but do not fit the data as well as a probit. 9 Failure to obtain provider data is attributable to two main reasons. First, the family did not give consent to contact the teen's vaccination provider. Second, communication with the provider was not possible because either contact information for the provider was not adequate or the provider did not respond. We estimated regressions that treat the unavailable vaccination records from the provider as missing, or use household data and include a dummy variable that represents when data from provider is missing, and Heckman probit model for selection. In all the cases, the results are qualitatively the same. more variables to further control for access to healthcare. First, we include a variable that indicates whether there was any period of the time after the age of 11 years that a teen did not have any health insurance coverage. Second, we include a variable that represents whether a child has visited a doctor in the past 12 months. We include a variable that represents whether a teen has had at least one shot of Tdap (tetanus, diphtheria, and pertussis) since age 10 years. Tdap vaccines are recommended for preteens aged 11 or 12 years, which is the same recommended age range for the HPV vaccine. It is likely that getting the Tdap vaccine influences the decision to initiate the HPV vaccine. Table A2 in the electronic supplementary file presents the summary statistics of these control covariates in states with school mandate in effect, states with educational programs for parents, and other states.
Finally, we include two other variables for state level policies as controls in the X vector. First, whether educational materials are provided to students is included and whether the state had a mandate in place that HPV vaccine must be covered under insurance. Both variables are merely controls, and we are not inferring casual effects of these policies. First, educational materials for students, even if a program was passed at the state level, is subject to local school districts to implement. Data on the extent to which these materials were distributed is not available. Second, health insurance requirements are heterogeneous in terms of covered age groups and cost sharing policies, and we cannot construct a well identified control group for this policy.
Identifying Causal Effects of Physician Recommendations
An underlying assumption of identification of causal effects through Eq. (1) is that the variables of interest (school mandate, education for parents, and recommendation) are exogenously determined. That is, they are not themselves correlated with unobservable factors that are driving the HPV vaccination decision. Most states introduced their regulations shortly after the vaccine was approved because of lobbying efforts by the manufacturers [24] . Since we include state and year dummies in the specifications, and most of these unobservable factors are unlikely to change over a course of our short 4-year period, the exogeneity assumption likely holds for the policy variables. Physician advice is more problematic in interpreting causal effects. First, parents who choose to vaccinate their child may be more likely to justify that decision by reporting a physician recommended it. Parents who place a higher value on their children's health might seek a recommendation for their daughters. On the other hand, physicians might recommend the vaccine more to those individuals who are likely involved in risky behaviors. We do control for general use of the healthcare system through control for health insurance status and doctor visits in the past year, but the data we have allow us to go further in identifying the role of physicians in certain instances. Given the population we study, there are a number of events that might trigger more or less interaction with physicians, which in turn would increase or decrease the chance that physicians would have to make the recommendation to be vaccinated. We have no reason to think that these events are systematically related to the unobservables affecting HPV vaccines once we control for our variables in the X vector. We therefore estimate the following instrumental variables probit model:
We use two excluded determinants of a physician recommendation in the Z vector of Eq. (2b)-asthma and checkup. These should be correlated with physician recommendations but have no correlation with the error term in Eq. (2a) for b 5 to be consistent. Asthma is an indicator of whether a child has ever been diagnosed with asthma. Clinical management of asthma involves regular monitoring by a physician [25] . We note that an asthma diagnosis does not guarantee visits in this age range, but they do increase the potential interaction with physicians and represent additional opportunities to recommend the HPV vaccine. This is ultimately corroborated in our data. Although asthma is more prevalent among minority children and those in poverty [26] , one would suspect none of these to influence vaccination rates positively once we control for health status, race, and parental characteristics. The second additional regressor in Eq. (2b) is checkup, which is set to one if a child had a child-well examination at ages 11 or 12 years, which are often mandated to attend school. 10 Wellness examinations plausibly identify another chance for the physician to suggest one get the HPV vaccine. 10 There are 35 states that have Tdap requirements for school entry. This includes Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyoming. Table 2 presents the results from the baseline regression (Eq. 1), where the dependent variable is vaccine initiation (dose C1), vaccine completion (dose C3), or an indicator for whether a child has initiated the HPV vaccine before the age of 13 years.
Results
Basic Estimates
Educational programs for parents have the expected positive effects for vaccine initiation, and vaccine completion, but the estimates are not statistically significant. The effect actually becomes negative and insignificant when we restrict the dependent variable to the vaccine initiation before the age of 13 years. Parents might be reluctant to vaccinate very young children against HPV given its sexually transmitted nature. We find the anticipated positive association between the school mandates and vaccine initiation among the girls between 13 and 17 years old. The point estimates are very close to what we obtained for educational programs for parents, but again the coefficients are not statistically significant. The effect of school mandates become smaller and remain insignificant when we restrict our outcome to the uptake status prior to age 13 years. 11 Physician recommendations do prove to be a strong predictor in all specifications, with marginal effects as high as 32 percentage points in terms of vaccine initiation, with a weaker effect for younger girls. The weaker effect may be the result of measuring the variable mid-sequence. Side effects might deter the parents from continuing the vaccination for younger children [27] . We fully acknowledge the potential pitfalls of interpreting the recommendation effect as causal and return to some additional tests in the next section. Regressions include state and year fixed effects, as well as the interactions of age and year. The numbers in parenthesis are robust standard errors *** p \ 0.01, ** p \ 0.05, * p \ 0.1 11 We conducted a series of robustness checks that we report and describe in the supplementary electronic file to ensure that the null effect of these state policies are accurate. Specifically, we address issue related to collinearity of the policies and comparability of comparison states to those with education and mandate policies. The null effects of both policies endure. Regressions include state and year fixed effects, as well as the interactions of age and year and all controls in Table 2 . The numbers in parenthesis are robust standard errors
Turning briefly to some of the other explanatory variables in Table 2 , impacts are in line with expectations with perhaps one exception. Income is negatively correlated with the vaccine outcomes after the age of 13 years. Lower income can lead to eligibility for governmental subsidies and increase the vaccination rate through this channel, which perhaps helps explain the inverse relationship.
Further Assessing the Physician's Role
The positive coefficient on physician's recommendation reported in Table 2 may be spurious if omitted factors like the health consciousness of parents is driving the relationship. We present the IV probit results, which identify physician recommendations from likely exogenous physician encounters, in Table 3 . We use two instruments initially to aid on identification-a history of asthma and an indicator of whether the person had a wellness examination intended for 11-or 12-year-olds. We think these visits would represent a chance for a physician to offer an HPV vaccine recommendation. Both variables strongly predict physician recommendations and their joint test of significance in the first stage yields an F-statistic range from 97-124.
The effect of physician recommendations in the IV probit remains strong and significant across all specifications. When compared with the effects in the probit model in Table 2 , the marginal effects are actually slightly higher in the IV model. This runs counter to the expectation that the bias would be positive in Table 2 . One probable explanation is that we are generating exogenous variation through variables, particularly a history of asthma, that may influence those from lower socioeconomic strata. One might expect the potential benefit from a physician recommendation to be higher since this group is starting from a lower baseline vaccine take-up rate.
Diagnostic Tests and Sensitivity Analysis
One drawback of using asthma and wellness checkups to determine physician recommendations is that we need to assume these characteristics do not determine vaccine uptake apart from their impact on physician recommendations. Given we use two instruments, however, we can switch from an IV probit to a two-stage least squares model and conduct over-identification tests. The results are qualitatively the same with two-stage least squares (2SLS), and we can use the Hansen test for over-identification, a restriction test in our 2SLS framework which is not available for IV probit. We assume asthma instrument to be uncorrelated with the structural error (e), which is required for the over-identification test. We run the regression using asthma as the only instrument, and compute the residuals (ê), and test whether the second instrument (checkup) and the computed residuals are correlated, and if they are, the second instrument is not a valid instrument. We cannot reject the null hypothesis that the correlation between checkup instrument and (ê) is zero, the p value is large (0.34-0.99 across the three vaccine measures), which allows us to be confident in the validity of our instrumental variables.
We also ran some additional IV probit models using alternative identifying variation in physician recommendations by using each of the instruments separately. First, we use a checkup instrument, and the results are presented in panel B of Table 3 . The results are nearly identical to those we obtained from using both instruments, and checkup is a strong predictor of receiving a physician recommendation. Second, since wellness examiantions were such a strong predictor of physician recommendations and a large proportion of the sample had such examinations, we conducted the IV probit with only a history of asthma as an excluded instrument. Reported in the panel C of Table 3 , the effects of physician recommendations are even stronger. As previously mentioned, the benefit from vaccination might be greater when we generate exogenous variation through history of asthma that may influence those from lower socioeconomic background. Since the local average treatment effect of asthma (i.e., the effect on those for whom we are identifying variation in physician recommendations) is likely to be greatest, this is not surprising. 12 
Discussion
Our paper compares the effectiveness of various policies to promote HPV vaccine uptake at the state level to physician recommendations. The rationale behind state-level mandates, the first policy we investigate, is to reduce not only infections among those who get the vaccine but potentially their sexual partners. Vaccination therefore creates externalities, and there must be population-level vaccination coordination, likely by the government, for this to happen [28] . Because of this externality argument, mandates are widely accepted, for example, among healthcare workers [29] . Because HPV vaccinations intersect with sexuality, restricting parental choice raises complications. So, an informational campaign through education might also be a way to increase immunization and the positive externality 12 In addition to two-stage least squares, we also estimated two-stage residual inclusion models using both history of asthma and checkup, and alternatively only history of asthma. In either case, the effect of physician recommendation remains a significant and strong predictor of all vaccine outcomes and the point estimates are even larger. These estimates are available upon request. associated with it. Such a communications-based approach can be effective [30] .
We find no consistent evidence, however, that in the few jurisdictions with school mandates that they are in any way effective at increasing take-up. This is despite the fact that one might expect these states to be more prevention-focused and willing to adhere to such mandates. Although a well-enforced mandate should be effective, there are strong opt-out provisions in both DC and Virginia. Virginia in particular allows a generous mandate that allows parents to decline the vaccine for any reason after they have reviewed materials on the link between HPV and cancer. 13 Moreover, states that attempt to educate parents about HPV have also not seen significant increases in take-up rates. Although education materials are widely available, there is no strong evidence that the materials are actually read and understood. We stress that additional study will become necessary as more states pass similar mandates. It would also be of importance to assess the effects of the policies in cases where opt-out provisions are not as liberal. This is an inherent limitation of studies at this stage.
On the other hand, physician recommendations prove overwhelmingly effective at increasing vaccine initiation and completion. We show that the effects have a casual component, as they are stronger in those cases where the recommendations likely stem from interactions with physicians for reasons unrelated to HPV vaccines. Promoting physician recommendations therefore seems to be good policy, as has been the case with influenza [14, 31] . It is sensible to consider why physician recommendations are not universal to begin with. With a physician rate of recommendation barely over 50 % in our data, it backs up claims that many physicians hesitate to recommend the vaccine [32] . There is evidence that physicians are less likely to recommend the vaccine when they are male, feeling uncomfortable discussing human sexuality issues with female patients [33] . Financial concerns including reimbursement for vaccination, and vaccine purchasing costs were cited as some of the most important perceived barriers to recommend the vaccine by physicians. Parents' opposition for moral or religious reasons was also perceived as a barrier to recommend the vaccine [3] .
We also found that physician advice was strongest in terms of initiating the vaccine, so providing parents with written and verbal reminders, and scheduling follow-up visits at the time of initial vaccination, could increase vaccine completion even more. This has worked in other settings, and the same strategies can be employed to increase the HPV vaccine completion rate [34] .
The role of providers' recommendations in decreasing racial and ethnic disparities has also been discussed in influenza vaccination literature, suggesting that the routine offering of influenza vaccine to minorities who make contact with the healthcare system for reasons other than vaccination can potentially decrease such disparities in influenza vaccination [12, 35] . There are significant ethnic and racial disparities in HPV vaccination [36, 37] , as well as cervical cancer incidence and its related mortalities [38] . This is a public health issue since those at higher risk are less likely to vaccinate or participate in cervical cancer screening programs [39] .
With evidence that physician advice encourages vaccination, increasing the prevalence of such advice, becomes a matter of policy concern. Considering the fact that Tdap booster is recommended for the same age range as the HPV vaccine, and taking into account that parents are less sensitive about Tdap shots, there is an opportunity for physicians to recommend the HPV vaccine at the time of Tdap vaccine uptake. The welfare implications and cost-benefit analysis of any of these policies need to be explored more and are left for future research.
Conclusions
We analyzed existing state-level mandates, which did not exhibit effectiveness increasing HPV vaccinations. Physician recommendations, however, are shown to be a strong predictor in HPV vaccine uptake.
